Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 113 Pages
Report ld: 5355739
Request Sample
Customized Report
The global Artificial Dermis market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Artificial Dermis market competitiveness, regional economic performance, and supply chain configurations.
The North America Artificial Dermis market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Artificial Dermis include MTF Biologics, Allosource, Parametrics Medical, LifeNet Health, Gunze, Tissue Regenix, Zimmer Biomet, Integra LifeSciences, Organogenesis, Flower Orthopedics, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Artificial Dermis market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Artificial Dermis market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., From Human Source in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Clinics in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Artificial Dermis value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Artificial Dermis Product Scope
1.2 Artificial Dermis by Type
1.2.1 Global Artificial Dermis Sales by Type (2020 & 2024 & 2031)
1.2.2 From Animal Source
1.2.3 From Human Source
1.3 Artificial Dermis by Application
1.3.1 Global Artificial Dermis Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Artificial Dermis Market Estimates and Forecasts (2020-2031)
1.4.1 Global Artificial Dermis Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Artificial Dermis Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Artificial Dermis Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Artificial Dermis Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Artificial Dermis Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Artificial Dermis Sales Market Share by Region (2020-2025)
2.2.2 Global Artificial Dermis Revenue Market Share by Region (2020-2025)
2.3 Global Artificial Dermis Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Artificial Dermis Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Artificial Dermis Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Artificial Dermis Market Size and Prospective (2020-2031)
2.4.2 Europe Artificial Dermis Market Size and Prospective (2020-2031)
2.4.3 China Artificial Dermis Market Size and Prospective (2020-2031)
2.4.4 Japan Artificial Dermis Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Artificial Dermis Historic Market Review by Type (2020-2025)
3.1.1 Global Artificial Dermis Sales by Type (2020-2025)
3.1.2 Global Artificial Dermis Revenue by Type (2020-2025)
3.1.3 Global Artificial Dermis Price by Type (2020-2025)
3.2 Global Artificial Dermis Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Artificial Dermis Sales Forecast by Type (2026-2031)
3.2.2 Global Artificial Dermis Revenue Forecast by Type (2026-2031)
3.2.3 Global Artificial Dermis Price Forecast by Type (2026-2031)
3.3 Different Types Artificial Dermis Representative Players
4 Global Market Size by Application
4.1 Global Artificial Dermis Historic Market Review by Application (2020-2025)
4.1.1 Global Artificial Dermis Sales by Application (2020-2025)
4.1.2 Global Artificial Dermis Revenue by Application (2020-2025)
4.1.3 Global Artificial Dermis Price by Application (2020-2025)
4.2 Global Artificial Dermis Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Artificial Dermis Sales Forecast by Application (2026-2031)
4.2.2 Global Artificial Dermis Revenue Forecast by Application (2026-2031)
4.2.3 Global Artificial Dermis Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Artificial Dermis Application
5 Competition Landscape by Players
5.1 Global Artificial Dermis Sales by Players (2020-2025)
5.2 Global Top Artificial Dermis Players by Revenue (2020-2025)
5.3 Global Artificial Dermis Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Dermis as of 2024)
5.4 Global Artificial Dermis Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Artificial Dermis, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Artificial Dermis, Product Type & Application
5.7 Global Key Manufacturers of Artificial Dermis, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Artificial Dermis Sales by Company
6.1.1.1 North America Artificial Dermis Sales by Company (2020-2025)
6.1.1.2 North America Artificial Dermis Revenue by Company (2020-2025)
6.1.2 North America Artificial Dermis Sales Breakdown by Type (2020-2025)
6.1.3 North America Artificial Dermis Sales Breakdown by Application (2020-2025)
6.1.4 North America Artificial Dermis Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Artificial Dermis Sales by Company
6.2.1.1 Europe Artificial Dermis Sales by Company (2020-2025)
6.2.1.2 Europe Artificial Dermis Revenue by Company (2020-2025)
6.2.2 Europe Artificial Dermis Sales Breakdown by Type (2020-2025)
6.2.3 Europe Artificial Dermis Sales Breakdown by Application (2020-2025)
6.2.4 Europe Artificial Dermis Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Artificial Dermis Sales by Company
6.3.1.1 China Artificial Dermis Sales by Company (2020-2025)
6.3.1.2 China Artificial Dermis Revenue by Company (2020-2025)
6.3.2 China Artificial Dermis Sales Breakdown by Type (2020-2025)
6.3.3 China Artificial Dermis Sales Breakdown by Application (2020-2025)
6.3.4 China Artificial Dermis Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Artificial Dermis Sales by Company
6.4.1.1 Japan Artificial Dermis Sales by Company (2020-2025)
6.4.1.2 Japan Artificial Dermis Revenue by Company (2020-2025)
6.4.2 Japan Artificial Dermis Sales Breakdown by Type (2020-2025)
6.4.3 Japan Artificial Dermis Sales Breakdown by Application (2020-2025)
6.4.4 Japan Artificial Dermis Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 MTF Biologics
7.1.1 MTF Biologics Company Information
7.1.2 MTF Biologics Business Overview
7.1.3 MTF Biologics Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
7.1.4 MTF Biologics Artificial Dermis Products Offered
7.1.5 MTF Biologics Recent Development
7.2 Allosource
7.2.1 Allosource Company Information
7.2.2 Allosource Business Overview
7.2.3 Allosource Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Allosource Artificial Dermis Products Offered
7.2.5 Allosource Recent Development
7.3 Parametrics Medical
7.3.1 Parametrics Medical Company Information
7.3.2 Parametrics Medical Business Overview
7.3.3 Parametrics Medical Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Parametrics Medical Artificial Dermis Products Offered
7.3.5 Parametrics Medical Recent Development
7.4 LifeNet Health
7.4.1 LifeNet Health Company Information
7.4.2 LifeNet Health Business Overview
7.4.3 LifeNet Health Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
7.4.4 LifeNet Health Artificial Dermis Products Offered
7.4.5 LifeNet Health Recent Development
7.5 Gunze
7.5.1 Gunze Company Information
7.5.2 Gunze Business Overview
7.5.3 Gunze Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Gunze Artificial Dermis Products Offered
7.5.5 Gunze Recent Development
7.6 Tissue Regenix
7.6.1 Tissue Regenix Company Information
7.6.2 Tissue Regenix Business Overview
7.6.3 Tissue Regenix Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Tissue Regenix Artificial Dermis Products Offered
7.6.5 Tissue Regenix Recent Development
7.7 Zimmer Biomet
7.7.1 Zimmer Biomet Company Information
7.7.2 Zimmer Biomet Business Overview
7.7.3 Zimmer Biomet Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Zimmer Biomet Artificial Dermis Products Offered
7.7.5 Zimmer Biomet Recent Development
7.8 Integra LifeSciences
7.8.1 Integra LifeSciences Company Information
7.8.2 Integra LifeSciences Business Overview
7.8.3 Integra LifeSciences Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Integra LifeSciences Artificial Dermis Products Offered
7.8.5 Integra LifeSciences Recent Development
7.9 Organogenesis
7.9.1 Organogenesis Company Information
7.9.2 Organogenesis Business Overview
7.9.3 Organogenesis Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Organogenesis Artificial Dermis Products Offered
7.9.5 Organogenesis Recent Development
7.10 Flower Orthopedics
7.10.1 Flower Orthopedics Company Information
7.10.2 Flower Orthopedics Business Overview
7.10.3 Flower Orthopedics Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Flower Orthopedics Artificial Dermis Products Offered
7.10.5 Flower Orthopedics Recent Development
7.11 Promethean
7.11.1 Promethean Company Information
7.11.2 Promethean Business Overview
7.11.3 Promethean Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Promethean Artificial Dermis Products Offered
7.11.5 Promethean Recent Development
7.12 Wright Medical Group
7.12.1 Wright Medical Group Company Information
7.12.2 Wright Medical Group Business Overview
7.12.3 Wright Medical Group Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Wright Medical Group Artificial Dermis Products Offered
7.12.5 Wright Medical Group Recent Development
7.13 Aziyo Biologics
7.13.1 Aziyo Biologics Company Information
7.13.2 Aziyo Biologics Business Overview
7.13.3 Aziyo Biologics Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Aziyo Biologics Artificial Dermis Products Offered
7.13.5 Aziyo Biologics Recent Development
7.14 RTI Surgical
7.14.1 RTI Surgical Company Information
7.14.2 RTI Surgical Business Overview
7.14.3 RTI Surgical Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
7.14.4 RTI Surgical Artificial Dermis Products Offered
7.14.5 RTI Surgical Recent Development
7.15 MiMedx Group
7.15.1 MiMedx Group Company Information
7.15.2 MiMedx Group Business Overview
7.15.3 MiMedx Group Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
7.15.4 MiMedx Group Artificial Dermis Products Offered
7.15.5 MiMedx Group Recent Development
7.16 Tides Medical
7.16.1 Tides Medical Company Information
7.16.2 Tides Medical Business Overview
7.16.3 Tides Medical Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
7.16.4 Tides Medical Artificial Dermis Products Offered
7.16.5 Tides Medical Recent Development
7.17 Ventris Medical
7.17.1 Ventris Medical Company Information
7.17.2 Ventris Medical Business Overview
7.17.3 Ventris Medical Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
7.17.4 Ventris Medical Artificial Dermis Products Offered
7.17.5 Ventris Medical Recent Development
7.18 Vivex Biomedical
7.18.1 Vivex Biomedical Company Information
7.18.2 Vivex Biomedical Business Overview
7.18.3 Vivex Biomedical Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
7.18.4 Vivex Biomedical Artificial Dermis Products Offered
7.18.5 Vivex Biomedical Recent Development
7.19 Aedicell
7.19.1 Aedicell Company Information
7.19.2 Aedicell Business Overview
7.19.3 Aedicell Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
7.19.4 Aedicell Artificial Dermis Products Offered
7.19.5 Aedicell Recent Development
7.20 Amniox Medical
7.20.1 Amniox Medical Company Information
7.20.2 Amniox Medical Business Overview
7.20.3 Amniox Medical Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
7.20.4 Amniox Medical Artificial Dermis Products Offered
7.20.5 Amniox Medical Recent Development
7.21 StimLabs
7.21.1 StimLabs Company Information
7.21.2 StimLabs Business Overview
7.21.3 StimLabs Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
7.21.4 StimLabs Artificial Dermis Products Offered
7.21.5 StimLabs Recent Development
7.22 Skye Biologics
7.22.1 Skye Biologics Company Information
7.22.2 Skye Biologics Business Overview
7.22.3 Skye Biologics Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
7.22.4 Skye Biologics Artificial Dermis Products Offered
7.22.5 Skye Biologics Recent Development
8 Artificial Dermis Manufacturing Cost Analysis
8.1 Artificial Dermis Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Artificial Dermis
8.4 Artificial Dermis Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Artificial Dermis Distributors List
9.3 Artificial Dermis Customers
10 Artificial Dermis Market Dynamics
10.1 Artificial Dermis Industry Trends
10.2 Artificial Dermis Market Drivers
10.3 Artificial Dermis Market Challenges
10.4 Artificial Dermis Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Artificial Dermis was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 160
USD 3950.00
(Single User License)
The global Artificial Dermis market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 146
USD 2900.00
(Single User License)
The global Artificial Dermis market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 196
USD 4900.00
(Single User License)
The global market for Artificial Dermis was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 160
USD 3950.00
(Single User License)
The global market for Artificial Dermis was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-01
Pages: 112
USD 2900.00
(Single User License)
The global Artificial Dermis market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-12
Pages: 127
USD 4900.00
(Single User License)
The global Artificial Dermis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-17
Pages: 109
USD 2900.00
(Single User License)
The global market for Artificial Dermis was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-07
Pages: 154
USD 3950.00
(Single User License)
The global market for Artificial Dermis was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 160
The global Artificial Dermis market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 146
The global Artificial Dermis market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 196
The global market for Artificial Dermis was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 160
The global market for Artificial Dermis was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-01
Pages: 112
The global Artificial Dermis market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-12
Pages: 127
The global Artificial Dermis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-17
Pages: 109
The global market for Artificial Dermis was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-07
Pages: 154
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now